search
Back to results

Preventive Intervention Against Lymphedema After Breast Cancer Surgery (LYCA)

Primary Purpose

Breast Neoplasms

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
exercise
Sponsored by
Danish Cancer Society
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Breast Neoplasms focused on measuring breast cancer surgery, axillary lymph node dissection, resistance training, breast cancer related lymphedema

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • invasive unilateral breast cancer
  • undergone Axillary Lymph Node Dissection (ALND), planned for Radiotherapy
  • Danish speaking
  • consent to participate and to be randomized to either study arm.

Exclusion Criteria:

  • have undergone primary breast reconstruction
  • distant metastases
  • physically unable to participate for any reason
  • mental illness or cognitive impairment (dementia etc.)
  • no past history of lymphedema diagnosis or treatment
  • not previously operated with axillary lymph node dissection either side

Sites / Locations

  • Danish Cancer Society Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

exercise group

usual care control group

Arm Description

The first 20 weeks, twice-weekly 60 minute session of physical exercise supervised by the research assistant and once weekly home exercise programme is offered. The exercise intervention will consist of stretching, scar tissue mobilization and resistance exercises. For the following 32 weeks a home-training manual specifying three times weekly training is provided. At week 26 an individual booster session will be offered. In the case of lymphedema, referral to trained lymphedema physiotherapist for evaluation of appropriate intervention is made.

Receives all standard care offered from the operating hospital and rehabilitation in the municipality.

Outcomes

Primary Outcome Measures

Number of participants with Lymphedema measured by water displacement measurement
Lymphedema is defined as >3% increase in inter limb volume difference compared to baseline, measured by ml. water displaced by lowering arm into a tub of water.

Secondary Outcome Measures

shoulder/arm/leg strength
change from baseline in Newtons in hand held dynometry and in 7RM tests for dynamic muscle strength.
patient reported pain
Pain through the study period measured on a pain scale developed to assess pain after breast cancer surgery by Gärtner et al (JAMA. 2009;302(18):1985-1992)
neuropathic pain
Measured by questionnaire assessment on neuropathic pain scale (NeuPPS).
Self-reported, Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-fatigue) questionnaire.
change from baseline in score on the FACIT-fatigue questionnaire
health related quality of life questionnaire
Change from baseline in Health-related quality of life Self-report, The European Organisation for Research and Treatment of Cancer (EORTC QLQ C30), breast cancer specific module (BR 23).
International Physical Activity Questionnaire (IPAQ)
Change in physical activity from baseline on the IPAQ
tissue composition by Dual Energy X-ray Apsorptiometry (DXA)
Change from baseline in tissue composition of bone mass, lean mass and fat mass, both regional and overall, assessed by Dual Energy X-ray absorptiometry (DXA).

Full Information

First Posted
August 4, 2015
Last Updated
September 12, 2018
Sponsor
Danish Cancer Society
Collaborators
Rigshospitalet, Denmark, Herlev Hospital, Ringsted sygehus
search

1. Study Identification

Unique Protocol Identification Number
NCT02518477
Brief Title
Preventive Intervention Against Lymphedema After Breast Cancer Surgery
Acronym
LYCA
Official Title
LYCA: Preventive Intervention Against Lymphedema After Breast Cancer Surgery - a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
September 2015 (undefined)
Primary Completion Date
January 31, 2018 (Actual)
Study Completion Date
January 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Danish Cancer Society
Collaborators
Rigshospitalet, Denmark, Herlev Hospital, Ringsted sygehus

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will examine whether lymphedema after breast cancer surgery can be reduced. In a randomised controlled design the aim is to investigate whether an early intervention with progressive resistance training and close monitoring of arm swelling can reduce the incidence of lymphedema after breast cancer surgery.
Detailed Description
Lymphedema is a well known and much dreaded complication after breast cancer surgery. The aim in this study is to examine if lymphedema can be prevented with early progressive strength training focusing on the arm, and close monitoring of pre clinical lymphedema in the 1 year exercise period. The primary outcome is lymphedema, and secondary outcomes are pain, self-reported symptoms of swelling, sensory disturbance, physical and psychological functioning, fatigue, depression, anxiety and health related quality of life. 158 patients operated for breast cancer with axillary node dissection, will be invited from three hospitals in Denmark, Sealand (Rigshospitalet, Ringsted Hospital, and Herlev Hospital), while on the surgical wards. Two weeks later upon consent they are recruited, baseline tested and randomized to either exercise intervention or usual care control. The exercise intervention consists of progressive resistance training, combined with a stretching programme, with a total duration of 60 minutes per session. The group attend supervised exercises twice a week and a once weekly home exercise programme of 45 to 60 minutes duration. After 20 weeks, exercises are converted to home exercises, and they are monitored by a weekly sms-service. At 12 months, follow-up measurements are taken for both groups. Lymphedema is defined as 3% limb volume change from the baseline measurement.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Neoplasms
Keywords
breast cancer surgery, axillary lymph node dissection, resistance training, breast cancer related lymphedema

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
158 (Actual)

8. Arms, Groups, and Interventions

Arm Title
exercise group
Arm Type
Experimental
Arm Description
The first 20 weeks, twice-weekly 60 minute session of physical exercise supervised by the research assistant and once weekly home exercise programme is offered. The exercise intervention will consist of stretching, scar tissue mobilization and resistance exercises. For the following 32 weeks a home-training manual specifying three times weekly training is provided. At week 26 an individual booster session will be offered. In the case of lymphedema, referral to trained lymphedema physiotherapist for evaluation of appropriate intervention is made.
Arm Title
usual care control group
Arm Type
No Intervention
Arm Description
Receives all standard care offered from the operating hospital and rehabilitation in the municipality.
Intervention Type
Other
Intervention Name(s)
exercise
Intervention Description
progressive resistance training
Primary Outcome Measure Information:
Title
Number of participants with Lymphedema measured by water displacement measurement
Description
Lymphedema is defined as >3% increase in inter limb volume difference compared to baseline, measured by ml. water displaced by lowering arm into a tub of water.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
shoulder/arm/leg strength
Description
change from baseline in Newtons in hand held dynometry and in 7RM tests for dynamic muscle strength.
Time Frame
12 months
Title
patient reported pain
Description
Pain through the study period measured on a pain scale developed to assess pain after breast cancer surgery by Gärtner et al (JAMA. 2009;302(18):1985-1992)
Time Frame
12 months
Title
neuropathic pain
Description
Measured by questionnaire assessment on neuropathic pain scale (NeuPPS).
Time Frame
12 months
Title
Self-reported, Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-fatigue) questionnaire.
Description
change from baseline in score on the FACIT-fatigue questionnaire
Time Frame
12 months
Title
health related quality of life questionnaire
Description
Change from baseline in Health-related quality of life Self-report, The European Organisation for Research and Treatment of Cancer (EORTC QLQ C30), breast cancer specific module (BR 23).
Time Frame
12 months
Title
International Physical Activity Questionnaire (IPAQ)
Description
Change in physical activity from baseline on the IPAQ
Time Frame
baseline and 12 months
Title
tissue composition by Dual Energy X-ray Apsorptiometry (DXA)
Description
Change from baseline in tissue composition of bone mass, lean mass and fat mass, both regional and overall, assessed by Dual Energy X-ray absorptiometry (DXA).
Time Frame
12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: invasive unilateral breast cancer undergone Axillary Lymph Node Dissection (ALND), planned for Radiotherapy Danish speaking consent to participate and to be randomized to either study arm. Exclusion Criteria: have undergone primary breast reconstruction distant metastases physically unable to participate for any reason mental illness or cognitive impairment (dementia etc.) no past history of lymphedema diagnosis or treatment not previously operated with axillary lymph node dissection either side
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Susanne Oksbjerg Dalton, MD PhD
Organizational Affiliation
Danish Cancer Society Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Danish Cancer Society Research Center
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark

12. IPD Sharing Statement

Learn more about this trial

Preventive Intervention Against Lymphedema After Breast Cancer Surgery

We'll reach out to this number within 24 hrs